Reversible binding of heparin to the loop peptide of endotoxin neutralizing protein

Journal of Endotoxin Research

Volumn 6, Issue 1, 2000, Pages 17-23

  Ridge, Richard J ^a   Paus, Erik J ^a   Novitsky, Thomas J ^a   Ketchum, Paul A ^a  

^a Associates of Cape Cod Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CHONDROITIN 4 SULFATE; CHONDROITIN 6 SULFATE; HEPARAN SULFATE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; POLYANETHOLESULFONIC ACID;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONSENSUS SEQUENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOELECTRIC POINT; LIMULUS;

BACTERIA (MICROORGANISMS); LIMULUS; LIMULUS POLYPHEMUS; NEGIBACTERIA; POLYPHEMUS;

EID: 0033919121     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/09680519000060010301     Document Type: Article

References (25)

1. Tobias PS, Mathison JC, Ulevitch RJ. A family of lipopolysaccharide binding proteins involved in response to Gram-negative sepsis. J Biol Chem 1988; 263: 13479-13481.
2. Weiss J, Elsbach P, Olsson I, Odeberg H. Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem 1978; 253: 2664-2672.
3. Larrick JW, Hirata M, Balint RF, Lee J, Zhong J, Wright SC. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect Immun 1995; 63: 1291-1297.
4. Selsted ME, Harwig SS, Ganz T, Schilling JW, Lehrer RI. Primary structures of antimicrobial peptides of rabbit peritoneal neutrophils. J Biol Chem 1985; 260: 4579-4584.
5. Lambert J, Keppi E, Dimarcq J-L et al. Insect immunity: isolation from immune blood of the dipteran Phormia terranovae of two insect antibacterial peptides with sequence homology to rabbit lung macrophage bactericidal peptides. Proc Natl Acad Sci USA 1989; 86: 262-266.
6. Pereira HA, Erdem I, Pohl J, Spitznagel JK. Synthetic bactericidal peptide based on CAP37: a 37-kDa human neutrophil granule-associated cationic antimicrobial protein chemotactic for monocytes. Proc Natl Acad Sci USA 1993; 90: 4733-4737.
7. Nilsson MF, Sandstedt B, Sørensen O, Weber G, Borregaard N, Stahle-Bäckdahl M. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect Immun 1999; 67: 2561-2566.
8. Iwanaga S, Miyata T, Tokunaga F, Muta T. Molecular mechanism of hemolymph clotting system in Limulus. Thrombos Res 1992; 68: 1-32.
9. Iwanaga S, Kawabata S, Muta T. New types of clotting factors and defense molecules found in horseshoe crab hemolymph: their structures and functions. J Biochem 1998; 123: 1-15.
10. Tanaka S, Nakamura T, Monta T, Iwanaga S. Limulus anti-LPS factor, an anticoagulant which inhibits the endotoxin mediated activation of Limulus coagulation system. Biochem Biophys Res Commun 1982; 105: 717-723.
11. Aketagawa J, Miyata T, Ohtsubo S et al. Primary structure of Limulus anticoagulant anti-lipopolysaccharide factor. J Biol Chem 1986; 261: 7357-7365.
12. Muta T, Miyata T, Tokunaga F, Nakamura R, Iwanaga S. Primary structure of anti-lipopolysaccharide factor from American horseshoe crab, Limulus polyphemus. J Biochem 1987; 101: 1321-1330.
13. Paus EJ, Ridge RJ, Legg CR, Novitsky TJ, Ketchum PA. Expression in yeast and purification of recombinant endotoxin neutralizing protein (rENP). Abstract RAFT II Society for Industrial Microbiology and American Chemical Society 1997; 31.
14. Hoess A, Watson S, Siber GR, Liddington R. Crystal structure of endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5 Å resolution. EMBO J 1993; 12: 3351-3356.
15. Morita T, Ohtsubo S, Nakamura T et al. Isolation and biological activities of Limulus anticoagulant (anti-LPS factor) which interacts with lipopolysaccharide (LPS). J Biochem 1985; 97: 1611-1620.
16. Kloczewiak M, Black KM, Loiselle P, Cavaillon J-M, Wainwright N, Warren HS. Synthetic peptides that mimic the binding site of horseshoe crab antilipopolysaccharide factor. J Infect Dis 1994; 170: 1490-1497.
17. Ried C, Wahl C, Miethke T et al. High affinity endotoxin-binding and neutralizing peptides based on the crystal structure of recombinant Limulus anti-lipopolysaccharide factor. J Biol Chem 1996; 271: 28120-28127.
18. Wainwright NR, Miller RM, Paus E et al. Endotoxin binding and neutralizing activity by a protein from Limulus polyphemus. In: Nowotny A, Spitzer JJ, Ziegler EJ. (eds) Cellular and Molecular Aspects of Endotoxin Reactions. New York, NY: Elsevier, 1990; 315-325.
19. Rosengart, TK, Johnson WV, Friesel, R, Clark R, Maciag T. Heparin protects heparin-binding growth factor-1 from proteolytic inactivation in vitro. Biochem Biophys Res Commun 1988; 152: 432-444.
20. Müller-Loennies S, Zähringer U, Seydel U, Kusumoto S, Ulmer AJ, Rietschel ET. What we know and don't know about the chemical and physical structure of lipopolysaccharide in relation to biological activity. In: Levin J, Pollack M, Yokochi T, Nakano M. (eds) Endotoxin and Sepsis Molecular Mechanisms of Pathogenesis. Host Resistance, and Therapy. New York, NY: Wiley-Liss, 1996; 51-72.
21. Cardin AD, Weintraub HJ. Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 1989; 9: 21-32.
22. 23). J Biol Chem 1994; 269: 1865-1872.
23. Mann DM, Romm E, Migliorini M. Delineation of the glycosaminoglycan-binding site in human inflammatory response protein lactoferrin. J Biol Chem 1994 269: 23661-23667.
24. Elass-Rochard E, Roseanu A, Legrand D et al. Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli O55B5 lipopolysaccharide. Biochem J 1995; 312: 839-845.
25. Battafarano RJ, Dahlberg PS, Ratz CA et al. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro. Surgery 1995; 118: 318-324.